BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Jun 28, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-06-27

Reporting Person: LEE KENNETH B JR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-06-27	Non-Qualified Stock Option	$3.80	A	22917	Acquired	2021-06-27	Common Stock (22917)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan (the "Plan").

F2: The option vests 1/12 per month for a period of 12 months, beginning on June 30, 2011.